rxstat › Classes › Hormonal Contraceptives For Systemic Use
Hormonal Contraceptives For Systemic Use: shortage status in Canada
6 of the 13 hormonal contraceptives for systemic use rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageDrospirenone Ethinyl Estradiol1 of 9 reported products affected · est. return Aug 10, 2026Partial shortageEthinyl Estradiol Desogestrel1 of 10 reported products affected · est. return Aug 20, 2026Partial shortageEthinyl Estradiol Levonorgestrel3 of 18 reported products affectedPartial shortageEthinyl Estradiol Levonorgestrel Ethinyl Estradiol1 of 1 reported products affectedPartial shortageEthinyl Estradiol Norethindrone4 of 10 reported products affected · est. return Mar 19, 2027Partial shortageNorethindrone1 of 4 reported products affected · est. return Aug 10, 2026DiscontinuedEthinyl Estradiol Ethinyl Estradiol Ethinyl Estradiol Norethindrone Norethindrone Norethindrone0 of 2 reported products affectedDiscontinuedEthinyl Estradiol Ethynodiol Diacetate0 of 2 reported products affectedDiscontinuedEthinyl Estradiol Norgestimate0 of 2 reported products affectedNo current shortageLevomefolate Drospirenone Ethinyl Estradiol LevomefolateNo current shortageLevonorgestrelDiscontinuedNorethindrone Ethinyl Estradiol Ethinyl Estradiol Norethindrone0 of 2 reported products affectedNo current shortageUlipristal
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.